Incyte Corp. will establish the new headquarters of Incyte Europe S.a.r.l in Geneva, Switzerland and expects to occupy the 9,000 sq. ft. facility by mid-2015. Incyte Europe will serve as the base for the conduct of its European clinical development operations. “The establishment of Incyte Europe in Geneva is a natural step in our company’s evolution,” said Hervé Hoppenot, president and chief executive officer of Incyte Corp. “Incyte has a broad and growing pipeline of proprietary, wholly-owned ...